Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00900224
First received: May 9, 2009
Last updated: June 27, 2016
Last verified: June 2016